Milestones of our company
Establishment of the state enterprise "Penicillin Factory", first penicillin production in central Europe
26. October 1949 production of penicillin was started.
Establishment of the antibacterial research institute VUAB
Production of streptomycin, infusion solutions, chloramphenicol, tetracycline, oxytetracycline, erythromycin, fungicides, neomycin, chloramphenicol and other.
Development and production in VUAB
Production of nystatin, sukcinylcholine iodide, pentobarbital, amifenazol, hydrocortisone, efedrine and other.
Privatization and acquisition of ICN Pharmaceuticals Inc.
VUAB transitions from state ownership to ICN Pharmaceuticals Inc.
Flood
The VUAB Pharma site was hit by a large flood.
June – VUAB becomes part of SAFICHEM GROUP AG
SAFICHEM GROUP AG becomes the owner with the strategy to keep production in the Czech Republic.
December – VUAB Pharma a.s.
Return to the original name VUAB, now VUAB Pharma a.s.
Acquisition of the production site in Brno
VUAB Pharma expands its portfolio with the production of oncological APIs.
Start of the construction of a new filling line
The construction of a new filling line for dry and liquid injections was started.
Acquisition of the production site in České Budějovice
VUAB Pharma acquires a new production site in České Budějovice - green synthesis of nucleosides, such as cladribine – API/FDFs.
VUAB Pharma celebrates 75 years of activity
For 75 years, we have been producing pharmaceutical products that combine tradition, quality and innovation.
Czech quality for better health worldwide
The excellent reputation that VUAB Pharma a.s. has earned in the field of the pharmaceutical industry is based on its tradition, experience, and responsible approach to employees.
About us